Koshiro Sonomoto

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Disease Activity

Systemic Lupus Erythematosus

Top Venues

Rheumatology and therapy

Rheumatology (Oxford, England)

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Yoshiya Tanaka, Kishimoto Mitsumasa, Koshiro Sonomoto, Koichi Amano, Masayoshi Harigai, Alina Onofrei, Jacqueline O'Brien, Zachary R Margolin, Christine Barr, Yasushi Mizuno, Ekta Agarwal, Naonobu Sugiyama, Hisashi Yamanaka
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study. Rheumatology and therapy (2024)
Hiroaki Tanaka, Yukinori Okada, Shingo Nakayamada, Yusuke Miyazaki, Kyuto Sonehara, Shinichi Namba, Suguru Honda, Yuya Shirai, Kenichi Yamamoto, Yasuyuki Todoroki, Katsunori Ikari, Masayoshi Harigai, Koshiro Sonomoto, Yoshiya Tanaka
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping. Annals of the rheumatic diseases (2023)
Yoshino Inoue, Shingo Nakayamada, Satoshi Kubo, Kaoru Yamagata, Koshiro Sonomoto, Shigeru Iwata, Yusuke Miyazaki, Yoshiya Tanaka
T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease. Rheumatology (Oxford, England) 61 (9) (2022)
Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Akio Kawabe, Yoshino Inoue, Naoaki Okubo, Shigeru Iwata, Kentaro Hanami, Yoshiya Tanaka
Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus. Rheumatology (Oxford, England) 61 (9) (2022)